Bascom Palmer Eye Institute
12
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
17%
2 trials in Phase 3/4
100%
9 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Role: collaborator
Ahmed Glaucoma Valve Surgery With Mitomycin-C
Role: collaborator
Shunt Tube Exposure Prevention Study
Role: collaborator
Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis
Role: collaborator
Non-Damaging Photothermal Therapy of Non-exudative Age Related Macular Degeneration
Role: collaborator
Prediction of Progression of Age-Related Macular Degeneration
Role: collaborator
A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Role: collaborator
Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency
Role: collaborator
Steroids After Laser Trabeculoplasty for Glaucoma
Role: collaborator
eSight Eyewear Quality of Life and Efficacy Study
Role: collaborator
Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression
Role: collaborator
Comparison of Patient Comfort After Two Anesthetic Protocols for Injections Into the Eye
Role: collaborator
All 12 trials loaded